These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24894373)

  • 1. In vitro method to observe E-selectin-mediated interactions between prostate circulating tumor cells derived from patients and human endothelial cells.
    Gakhar G; Bander NH; Nanus DM
    J Vis Exp; 2014 May; (87):. PubMed ID: 24894373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow.
    Gakhar G; Navarro VN; Jurish M; Lee GY; Tagawa ST; Akhtar NH; Seandel M; Geng Y; Liu H; Bander NH; Giannakakou P; Christos PJ; King MR; Nanus DM
    PLoS One; 2013; 8(12):e85143. PubMed ID: 24386459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score.
    Kolostova K; Broul M; Schraml J; Cegan M; Matkowski R; Fiutowski M; Bobek V
    Anticancer Res; 2014 Jul; 34(7):3641-6. PubMed ID: 24982381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands.
    He W; Kularatne SA; Kalli KR; Prendergast FG; Amato RJ; Klee GG; Hartmann LC; Low PS
    Int J Cancer; 2008 Oct; 123(8):1968-73. PubMed ID: 18661519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood.
    Hughes AD; Mattison J; Western LT; Powderly JD; Greene BT; King MR
    Clin Chem; 2012 May; 58(5):846-53. PubMed ID: 22344286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of human umbilical vein endothelial cells and their use in the study of neutrophil transmigration under flow conditions.
    Ganguly A; Zhang H; Sharma R; Parsons S; Patel KD
    J Vis Exp; 2012 Aug; (66):e4032. PubMed ID: 22895248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycomechanics of the metastatic cascade: tumor cell-endothelial cell interactions in the circulation.
    Geng Y; Marshall JR; King MR
    Ann Biomed Eng; 2012 Apr; 40(4):790-805. PubMed ID: 22101756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells.
    Mitchell MJ; Chen CS; Ponmudi V; Hughes AD; King MR
    J Control Release; 2012 Jun; 160(3):609-17. PubMed ID: 22421423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs).
    Myung JH; Launiere CA; Eddington DT; Hong S
    Langmuir; 2010 Jun; 26(11):8589-96. PubMed ID: 20155985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.
    Chen J; Cao S; Situ B; Zhong J; Hu Y; Li S; Huang J; Xu J; Wu S; Lin J; Zhao Q; Cai Z; Zheng L; Wang Q
    J Exp Clin Cancer Res; 2018 Jun; 37(1):127. PubMed ID: 29954422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel three-dimensional flow chamber device to study chemokine-directed extravasation of cells circulating under physiological flow conditions.
    Goncharova V; Khaldoyanidi SK
    J Vis Exp; 2013 Jul; (77):e50959. PubMed ID: 23893091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms by which E-selectin regulates diapedesis of colon cancer cells under flow conditions.
    Tremblay PL; Huot J; Auger FA
    Cancer Res; 2008 Jul; 68(13):5167-76. PubMed ID: 18593916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells.
    Williams ES; Rodriguez-Bravo V; Chippada-Venkata U; De Ia Iglesia-Vicente J; Gong Y; Galsky M; Oh W; Cordon-Cardo C; Domingo-Domenech J
    J Vis Exp; 2015 Oct; (105):53182. PubMed ID: 26555435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time in vivo imaging of subpopulations of circulating tumor cells using antibody conjugated quantum dots.
    Kuo CW; Chueh DY; Chen P
    J Nanobiotechnology; 2019 Feb; 17(1):26. PubMed ID: 30728024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Studies on Viable Circulating Tumor Cells.
    Pantel K; Alix-Panabières C
    Clin Chem; 2016 Feb; 62(2):328-34. PubMed ID: 26637479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
    Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L
    Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization of tumor cell extravasation.
    Heyder C; Gloria-Maercker E; Hatzmann W; Zaenker KS; Dittmar T
    Contrib Microbiol; 2006; 13():200-208. PubMed ID: 16627967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenic potential of circulating prostate tumor cells.
    Carvalho FL; Simons BW; Antonarakis ES; Rasheed Z; Douglas N; Villegas D; Matsui W; Berman DM
    Oncotarget; 2013 Mar; 4(3):413-21. PubMed ID: 23530114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.
    Mout L; van Dessel LF; Kraan J; de Jong AC; Neves RPL; Erkens-Schulze S; Beaufort CM; Sieuwerts AM; van Riet J; Woo TLC; de Wit R; Sleijfer S; Hamberg P; Sandberg Y; Te Boekhorst PAW; van de Werken HJG; Martens JWM; Stoecklein NH; van Weerden WM; Lolkema MP
    Eur J Cancer; 2021 Jun; 150():179-189. PubMed ID: 33932725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer.
    Magbanua MJ; Sosa EV; Scott JH; Simko J; Collins C; Pinkel D; Ryan CJ; Park JW
    BMC Cancer; 2012 Feb; 12():78. PubMed ID: 22373240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.